Tempest Therapeutics Inc. (NASDAQ: TPST) Stock Information | RedChip

Tempest Therapeutics Inc. (NASDAQ: TPST) Listen to this Section


$1.56
+0.3650 ( +30.67% ) 101.9M

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Market Data


Open


$1.56

Previous close


$1.19

Volume


101.9M

Market cap


$39.07M

Day range


$1.18 - $2.16

52 week range


$0.17 - $9.77

Insider Ownership Transactions

Total Amount Purchased: -400,000.00 | $ -622,000.00

Date Type Amount Purchased Purchaser
2024-08-12 Sale -400000.00 Versant Venture Capital VI, L.P.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 12, 2024
10-q Quarterly Reports 56 Aug 08, 2024
8-k 8K-related 13 Aug 08, 2024
4 Insider transactions 1 Jul 08, 2024
4 Insider transactions 1 Jul 03, 2024
4 Insider transactions 1 Jul 02, 2024
8-k 8K-related 19 Jun 20, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
8-k 8K-related 14 Jun 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.